TELA Bio, Inc. Common Stock (TELA) is a publicly traded Healthcare sector company. As of October 27, 2026, TELA trades at $0.97 with a market cap of $44.31M and a P/E ratio of -1.53. TELA moved +0.00% today. Year to date, TELA is -15.79%; over the trailing twelve months it is -35.14%. Its 52-week range spans $0.50 to $2.52. Analyst consensus is strong buy with an average price target of $1.75. Rallies surfaces TELA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TELA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TELA recently traded at $0.97. Market cap is $44.31M. P/E ratio is -1.53. Revenue is $79.91M.
| Metric | Value |
|---|---|
| Price | $0.97 |
| Market Cap | $44.31M |
| P/E Ratio | -1.53 |
| EPS | $-0.77 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.52 |
| 52-Week Low | $0.50 |
| Volume | 41.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $79.91M |
| Net Income | $-41.18M |
| Gross Margin | 67.81% |
4 analysts cover TELA: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1.75.